Navigation Links
Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
Date:8/28/2008

SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Thomas Weisel Healthcare Conference in Boston on Wednesday, September 3, 2008 at 9:10 a.m. ET, at the BioCentury NewsMakers Conference in New York on Thursday, September 4, 2008 at 11:30 a.m. ET, and at the Morgan Stanley Global Healthcare Unplugged Conference in New York on Tuesday, September 9, 2008 at 10:55 a.m. ET. Mark G. Foletta, Amylin's Senior Vice President of Finance and Chief Financial Officer, will be providing corporate overviews at Thomas Weisel and BioCentury. Daniel M. Bradbury, Amylin's President and Chief Executive Officer, will be providing a corporate overview at Morgan Stanley.

The live presentations will be Web cast, and recordings will be made available following the event. The Web casts and recordings will be accessible through Amylin's corporate Web site, located at http://www.amylin.com. To access the live Web casts, please log on to Amylin's site approximately fifteen minutes prior to the presentations to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 2,000 empl
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... BELLINGHAM, Washington, USA (PRWEB) May 26, 2015 ... a formal partnership with the Max Planck Society ... Extreme and Quantum Photonics. The center will link two ... of photonics, and will be only the third Max ... SPIE, the international society for optics and photonics, ...
(Date:5/26/2015)... HILDEN, Germany , May 26, ... QGEN ; Frankfurt Prime Standard: QIA) today ... Insight ® (QCI™) bioinformatics content and software ... report on genomic variants identified in next-generation sequencing ... bioinformatics platform are in oncology, for somatic and ...
(Date:5/26/2015)... Miami, FL (PRWEB) May 26, 2015 ... training, Inc. have announced plans for the company’s first ... 9, 2015, followed by a full day, hands-on stem ... hosted by J. Victor Garcia Gimenez, M.D., President of ... to the medical community’s increasing interest in regenerative medicine ...
(Date:5/26/2015)... 2015 Leading Regenerative Veterinary Medicine® ... long-term relationship with Veterinary Growth Partners, a membership ... to provide access to vital services to veterinary ... VGP as a dedicated partner in bringing stem ... Concentrating and using stem cells natural abilities to ...
Breaking Biology Technology:Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 3
... gotten the law wrong. Why should ... we trust them to get cures right?, ST. ... opponents of stem cell cures refiled,their measure yet again, the third ... of Missouri Coalition for Lifesaving Cures, "In,their zeal to repeal stem ...
... Audio Webcast Friday, September 7, 2007, SAN DIEGO, ... announced today that Neurocrine Biosciences will,present at the Thomas ... September 7, 2007 at 11:30 a.m. Eastern,Time (ET) /8:30 ... and may be accessed on the Company,s website at, ...
... 99% Year-Over-Year, SHANGHAI, China, Sept. 5 ... WX ) ("WuXi PharmaTech" or "the Company"), ... development,outsourcing company, today announced its unaudited financial ... 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), ...
Cached Biology Technology:3 strikes, you're out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause 2WuXi PharmaTech Announces Second Quarter 2007 Results 2WuXi PharmaTech Announces Second Quarter 2007 Results 3WuXi PharmaTech Announces Second Quarter 2007 Results 4WuXi PharmaTech Announces Second Quarter 2007 Results 5WuXi PharmaTech Announces Second Quarter 2007 Results 6WuXi PharmaTech Announces Second Quarter 2007 Results 7WuXi PharmaTech Announces Second Quarter 2007 Results 8WuXi PharmaTech Announces Second Quarter 2007 Results 9WuXi PharmaTech Announces Second Quarter 2007 Results 10
(Date:4/17/2015)... , April 17, 2015 ... concerns, and technological advancement to drive biometric systems ... until 2020   According to a ... Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... to register growth at CAGR of over 22% ...
(Date:4/13/2015)... NEW YORK , April 13, 2015 /PRNewswire/ ... study by TechSci Research, "Global Biometrics Market Forecast & ... to register a CAGR of around 14% till ... various governments for large scale implementation and review ... technology and launch of new products with greater ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... standard practice of giving infants and children 100 percent ... may actually inflict additional harm, researchers at UT Southwestern ... oxygen deprivation, known as hypoxic-ischemic brain injury, is one ... neurological damage among infants and children. This can happen ...
... La Jolla, Calif., June 30, 2008--In a breakthrough scientific ... National Academy of Sciences , scientists at the Burnham ... cell development may be linked to Autism. The study ... (MEF2C) protein in neural stem cells had smaller brains, ...
... The dream of personalized medicine in which diagnostics, risk ... profile may be on the verge of being expanded ... of researchers with the U.S. Department of Energy,s Lawrence Berkeley ... DNA or RNA assays the key to genetic profiling ...
Cached Biology News:Resuscitation technique after brain injury may do more harm than good 2Researchers link early stem cell mutation to autism 2New electrostatic-based DNA microarray technique could revolutionize medical diagnostics 2New electrostatic-based DNA microarray technique could revolutionize medical diagnostics 3New electrostatic-based DNA microarray technique could revolutionize medical diagnostics 4
... is a four-channel general purpose laboratory amplifier. It ... sources which may have a large common-mode level ... a high gain/low noise amplifier, an input coupling ... offset control. A control knob sets the amplifier ...
... Pro-OpioMelanoCortin (POMC) has long been a ... precursor to a multiplicity of biologically-active ... -endorphin, Alpha-Melanocyte Stimulating Hormone (a-MSH) and ... well-conserved molecule, being found in most ...
...
...
Biology Products: